ATLANTA, Georgia, Sept. 16 (TNSLrpt) -- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention issued the following document as part of its Morbidity and Mortality Weekly Report (No. 31) on August 21, 2025, entitled "Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination -- United States, October 2023-March 2024.":

Here are excerpts:

* * *